Vijayavalli Dhanapal

发表

Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study

R. Marcus, D. Wrench, P. Fields, 2017, Leukemia and Lymphoma.

Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma

E. Tholouli, J. Snowden, J. Cavenagh, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.